AB-1003
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AB-1003, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1) [Phase 1, Phase 2]